Evidence map›Paper›PMID 33123723›Full record

ArticleThe Journal of clinical endocrinology and metabolism2021

The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat.

Lars Lind, Samira Salihovic, Ulf Risérus, Joel Kullberg, Lars Johansson, Håkan Ahlström, Jan W Eriksson, Jan Oscarsson

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Hepatic Steatosis and Fibrosis, Cardiorespiratory Fitness, and Metabolic Mediators in the Community.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Proton density fat fraction: magnetic resonance imaging applications beyond the liver.Diagnostic and interventional radiology (Ankara, Turkey) · 2022
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Lars LindDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Samira SalihovicSchool of Medical Sciences, Örebro University, Örebro, Sweden.
Ulf RisérusDepartment of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
Joel KullbergAntaros Medical AB, Gothenburg, Sweden.
Lars JohanssonAntaros Medical AB, Gothenburg, Sweden.
Håkan AhlströmAntaros Medical AB, Gothenburg, Sweden.
Jan W ErikssonDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Jan OscarssonBioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Uppsala University · SEAntaros Medical (Sweden) · SEAstraZeneca (Sweden) · SEÖrebro University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextMetabolic differences between ectopic fat depots may provide novel insights to obesity-related diseases.

objectiveTo investigate the plasma metabolomic profiles in relation to visceral adipose tissue (VAT) volume and liver and pancreas fat percentages.

designCross-sectional.

settingMulticenter at academic research laboratories. PATIENTS: Magnetic resonance imaging (MRI) was used to assess VAT volume, the percentage of fat in the liver and pancreas (proton density fat fraction [PDFF]) at baseline in 310 individuals with a body mass index ≥ 25 kg/m2 and with serum triglycerides ≥ 1.7 mmol/l and/or type 2 diabetes screened for inclusion in the 2 effect of omega-3 carboxylic acid on liver fat content studies.

interventionNone.

main outcome measureMetabolomic profiling with mass spectroscopy enabled the determination of 1063 plasma metabolites.

resultsThirty metabolites were associated with VAT volume, 31 with liver PDFF, and 2 with pancreas PDFF when adjusting for age, sex, total body fat mass, and fasting glucose. Liver PDFF and VAT shared 4 metabolites, while the 2 metabolites related to pancreas PDFF were unique. The top metabolites associated with liver PDFF were palmitoyl-palmitoleoyl-GPC (16:0/16:1), dihydrosphingomyelin (d18:0/22:0), and betaine. The addition of these metabolites to the Liver Fat Score improved C-statistics significantly (from 0.776 to 0.861, P = 0.0004), regarding discrimination of liver steatosis.

conclusionLiver PDFF and VAT adipose tissue shared several metabolic associations, while those were not shared with pancreatic PDFF, indicating partly distinct metabolic profiles associated with different ectopic fat depots. The addition of 3 metabolites to the Liver Fat Score improved the prediction of liver steatosis.

Indexed as

MetabolomeAdiposityAdultAgedBloodCohort StudiesCross-Sectional StudiesDiabetes Mellitus, Type 2Fatty LiverFemaleHumansIntra-Abdominal FatLipid MetabolismLiverMagnetic Resonance ImagingMaleectopic fatliver fatmetabolomicsMRIobesitypancreatic fat

Identifiers

PMID33123723
PMCPMC7765636
OpenAlexW3097793914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.